These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15385494)

  • 1. Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.
    Elder KD; Harvill ET
    Infect Immun; 2004 Oct; 72(10):5919-24. PubMed ID: 15385494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates.
    Stefanelli P; Sanguinetti M; Fazio C; Posteraro B; Fadda G; Mastrantonio P
    J Clin Microbiol; 2006 Sep; 44(9):3397-400. PubMed ID: 16954284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BapC autotransporter protein is a virulence determinant of Bordetella pertussis.
    Noofeli M; Bokhari H; Blackburn P; Roberts M; Coote JG; Parton R
    Microb Pathog; 2011 Sep; 51(3):169-77. PubMed ID: 21554944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.
    Pilione MR; Pishko EJ; Preston A; Maskell DJ; Harvill ET
    Infect Immun; 2004 May; 72(5):2837-42. PubMed ID: 15102794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bordetella pertussis acquires resistance to complement-mediated killing in vivo.
    Pishko EJ; Betting DJ; Hutter CS; Harvill ET
    Infect Immun; 2003 Sep; 71(9):4936-42. PubMed ID: 12933835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O antigen protects Bordetella parapertussis from complement.
    Goebel EM; Wolfe DN; Elder K; Stibitz S; Harvill ET
    Infect Immun; 2008 Apr; 76(4):1774-80. PubMed ID: 18285500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection.
    Vergara-Irigaray N; Chávarri-Martínez A; Rodríguez-Cuesta J; Miller JF; Cotter PA; Martínez de Tejada G
    Infect Immun; 2005 Feb; 73(2):748-60. PubMed ID: 15664913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2003 Feb; 71(2):733-8. PubMed ID: 12540552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Bordetella O antigen in respiratory tract infection.
    Burns VC; Pishko EJ; Preston A; Maskell DJ; Harvill ET
    Infect Immun; 2003 Jan; 71(1):86-94. PubMed ID: 12496152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.
    Carbonetti NH; Artamonova GV; Andreasen C; Dudley E; Mays RM; Worthington ZE
    Infect Immun; 2004 Jun; 72(6):3350-8. PubMed ID: 15155640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to BrkA augment killing of Bordetella pertussis.
    Oliver DC; Fernandez RC
    Vaccine; 2001 Oct; 20(1-2):235-41. PubMed ID: 11567769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.
    Wolfe DN; Kirimanjeswara GS; Harvill ET
    Infect Immun; 2005 Oct; 73(10):6508-13. PubMed ID: 16177324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.
    Harvill ET; Preston A; Cotter PA; Allen AG; Maskell DJ; Miller JF
    Infect Immun; 2000 Dec; 68(12):6720-8. PubMed ID: 11083787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of BrkA expression in Bordetella bronchiseptica.
    Rambow AA; Fernandez RC; Weiss AA
    Infect Immun; 1998 Aug; 66(8):3978-80. PubMed ID: 9673291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection.
    Harvill ET; Cotter PA; Miller JF
    Infect Immun; 1999 Nov; 67(11):6109-18. PubMed ID: 10531274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 17. The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.
    Ganguly T; Johnson JB; Kock ND; Parks GD; Deora R
    Cell Microbiol; 2014 Jul; 16(7):1105-18. PubMed ID: 24438122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.
    Ho SY; Chua SQ; Foo DG; Locht C; Chow VT; Poh CL; Alonso S
    Infect Immun; 2008 Jan; 76(1):111-9. PubMed ID: 17954727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative role of immunoglobulin A in protective immunity against the Bordetellae.
    Wolfe DN; Kirimanjeswara GS; Goebel EM; Harvill ET
    Infect Immun; 2007 Sep; 75(9):4416-22. PubMed ID: 17591791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.
    Packard ER; Parton R; Coote JG; Fry NK
    J Med Microbiol; 2004 May; 53(Pt 5):355-365. PubMed ID: 15096543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.